Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_2

PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC

NCT06156891
unknownnot_applicable

De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT04158518
unknownnot_applicable

De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations

NCT04012502

Clinical Trials (3)

Showing 3 of 3 trials
NCT06156891Phase 2

PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC

Unknown
NCT04158518Not Applicable

De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma

Unknown
NCT04012502Not Applicable

De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3